The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer.
Open accessAbstract
The major target of the neutralizing antibody response to infection by the human immunodeficiency virus type 1 (HIV-1) is the outer envelope glycoprotein, gp120. The spectrum of HIV-1 neutralization specificity is currently represented by monoclonal antibodies (mAbs) that can be divided broadly into five groups. We have studied the binding of these mAbs to functional oligomeric and soluble monomeric gp120 derived from the molecular clone of a cell line-adapted isolate of HIV-1, and compared these binding properties with virus neutralization. Binding of all mAbs except those reactive with the V3 loop was much weaker to oligomeric than to monomeric gp120. This reduction in binding to oligomeric gp120 was determined mostly by a slower relative rate of association, although the dissociation rate also had some influence on relative variation in mAb affinity. Virus neutralization correlated broadly with mAb binding to the oligomeric rather than to the monomeric form of gp120, and neutralization potency was related to the estimated association rate. Thus, with the exception of the hypervariable V3 loop, regions of HIV-1 gp120 with the potential to induce a neutralization response are likely to be poorly presented for antibody recognition on the surface of cell line-adapted virions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F., & Weiss, R. A. (1984) · Nature · doi:10.1038/312763a0 · Cited by 3,533
Pathogenesis of human immunodeficiency virus infection
Levy, J. A. (1993) · Microbiological Reviews · doi:10.1128/mr.57.1.183-289.1993 · Cited by 839
Lasky, L. A., Nakamura, G., Smith, D. H., Fennie, C., Shimasaki, C., Patzer, E., Berman, P., Gregory, T., & Capon, D. J. (1987) · Cell · doi:10.1016/0092-8674(87)90524-1 · Cited by 828
Thali, M., Moore, J. P., Furman, C., Charles, M., Ho, D. D., Robinson, J., & Sodroski, J. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.3978-3988.1993 · Cited by 616
Self-citationSattentau, Q. J., & Moore, J. P. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.2.407 · Cited by 600
Self-citationPalker, T. J., Clark, M. E., Langlois, A. J., Matthews, T. J., Weinhold, K. J., Randall, R. R., Bolognesi, D. P., & Haynes, B. F. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.6.1932 · Cited by 532
The CD4 antigen: Physiological ligand and HIV receptor
Sattentau, Q. J., & Weiss, R. A. (1988) · Cell · doi:10.1016/0092-8674(88)90397-2 · Cited by 413
Self-citationOlshevsky, U., Helseth, E., Furman, C., Li, J., Haseltine, W., & Sodroski, J. (1990) · Journal of Virology · doi:10.1128/jvi.64.12.5701-5707.1990 · Cited by 405
Moore, J. P., Cao, Y., Qing, L., Sattentau, Q. J., Pyati, J., Koduri, R., Robinson, J., Barbas, C. F., Burton, D. R., & Ho, D. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.101-109.1995 · Cited by 401
Self-citationOligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein.
Earl, P. L., Doms, R. W., & Moss, B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.2.648 · Cited by 359
Cited by
The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
Wyatt, R., & Sodroski, J. (1998) · Science · doi:10.1126/science.280.5371.1884 · Cited by 1,598
The antigenic structure of the HIV gp120 envelope glycoprotein
Wyatt, R., Kwong, P. D., Desjardins, E., Sweet, R. W., Robinson, J., Hendrickson, W. A., & Sodroski, J. G. (1998) · Nature · doi:10.1038/31514 · Cited by 1,203
Zwick, M. B., Labrijn, A. F., Wang, M., Spenlehauer, C., Saphire, E. O., Binley, J. M., Moore, J. P., Stiegler, G., Katinger, H., Burton, D. R., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10892-10905.2001 · Cited by 797
Self-citationA Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
Pejchal, R., Doores, K. J., Walker, L. M., Khayat, R., Huang, P.-S., Wang, S.-K., Stanfield, R. L., Julien, J.-P., Ramos, A., Crispin, M., et al. (2011) · Science · doi:10.1126/science.1213256 · Cited by 694
Self-citationScanlan, C. N., Pantophlet, R., Wormald, M. R., Saphire, E. O., Stanfield, R., Wilson, I. A., Katinger, H., Dwek, R. A., Rudd, P. M., & Burton, D. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7306-7321.2002 · Cited by 665
Parren, P. W. H. I., Marx, P. A., Hessell, A. J., Luckay, A., Harouse, J., Cheng-Mayer, C., Moore, J. P., & Burton, D. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.17.8340-8347.2001 · Cited by 662
Self-citationAntibodies, viruses and vaccines
Burton, D. R. (2002) · Nature Reviews Immunology · doi:10.1038/nri891 · Cited by 637
Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
Burton, D. R., & Hangartner, L. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055515 · Cited by 583
Binley, J. M., Sanders, R. W., Clas, B., Schuelke, N., Master, A., Guo, Y., Kajumo, F., Anselma, D. J., Maddon, P. J., Olson, W. C., et al. (2000) · Journal of Virology · doi:10.1128/jvi.74.2.627-643.2000 · Cited by 534
Self-citationHessell, A. J., Rakasz, E. G., Poignard, P., Hangartner, L., Landucci, G., Forthal, D. N., Koff, W. C., Watkins, D. I., & Burton, D. R. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000433 · Cited by 497
Exploitation of glycosylation in enveloped virus pathobiology
Watanabe, Y., Bowden, T. A., Wilson, I. A., & Crispin, M. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.05.012 · Cited by 482
Trkola, A., Pomales, A. B., Yuan, H., Korber, B., Maddon, P. J., Allaway, G. P., Katinger, H., Barbas, C. F., Burton, D. R., & Ho, D. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.6609-6617.1995 · Cited by 480
GP120: Target for Neutralizing HIV-1 Antibodies
Pantophlet, R., & Burton, D. R. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090557 · Cited by 445
Sanders, R. W., Vesanen, M., Schuelke, N., Master, A., Schiffner, L., Kalyanaraman, R., Paluch, M., Berkhout, B., Maddon, P. J., Olson, W. C., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.17.8875-8889.2002 · Cited by 440
Self-citationEnergetics of the HIV gp120-CD4 binding reaction
Myszka, D. G., Sweet, R. W., Hensley, P., Brigham-Burke, M., Kwong, P. D., Hendrickson, W. A., Wyatt, R., Sodroski, J., & Doyle, M. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.9026 · Cited by 422
A Blueprint for HIV Vaccine Discovery
Burton, D. R., Ahmed, R., Barouch, D. H., Butera, S. T., Crotty, S., Godzik, A., Kaufmann, D. E., McElrath, M. J., Nussenzweig, M. C., Pulendran, B., et al. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.09.008 · Cited by 375
Binley, J. M., Lybarger, E. A., Crooks, E. T., Seaman, M. S., Gray, E., Davis, K. L., Decker, J. M., Wycuff, D., Harris, L., Hawkins, N., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01762-08 · Cited by 355
Antiviral antibody responses: the two extremes of a wide spectrum
Hangartner, L., Zinkernagel, R. M., & Hengartner, H. (2006) · Nature Reviews Immunology · doi:10.1038/nri1783 · Cited by 314
Moulard, M., Lortat-Jacob, H., Mondor, I., Roca, G., Wyatt, R., Sodroski, J., Zhao, L., Olson, W., Kwong, P. D., & Sattentau, Q. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.4.1948-1960.2000 · Cited by 297
Self-citationSullivan, N., Sun, Y., Sattentau, Q., Thali, M., Wu, D., Denisova, G., Gershoni, J., Robinson, J., Moore, J., & Sodroski, J. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.4694-4703.1998 · Cited by 292
Self-citationHartley, O., Klasse, P. J., Sattentau, Q. J., & Moore, J. P. (2005) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2005.21.171 · Cited by 290
Self-citationOccupancy and mechanism in antibody-mediated neutralization of animal viruses
Klasse, P. J., & Sattentau, Q. J. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-9-2091 · Cited by 287
Self-citationYang, X., Lee, J., Mahony, E. M., Kwong, P. D., Wyatt, R., & Sodroski, J. (2002) · Journal of Virology · doi:10.1128/jvi.76.9.4634-4642.2002 · Cited by 277
The antiviral activity of antibodies in vitro and in vivo
Parren, P. W. H. I., & Burton, D. R. (2001) · Advances in Immunology · doi:10.1016/s0065-2776(01)77018-6 · Cited by 261
Syndecans Serve as Attachment Receptors for Human Immunodeficiency Virus Type 1 on Macrophages
Saphire, A. C. S., Bobardt, M. D., Zhang, Z., David, G., & Gallay, P. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.19.9187-9200.2001 · Cited by 255
Immunopathogenesis of HIV Infection
Fox, L. M. (2002) · Immunotherapy for Infectious Diseases · doi:10.1007/978-1-59259-171-8_8 · Cited by 254
Metadata
- Authors
- Sattentau, Q. J., & Moore, J. P.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1995-07-01
- Volume
- 182
- Issue
- 1
- Pages
- 185-196
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2131906141
- Cited by
- 334
- References
- 38
- FWCI
- 7.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.